PHARMACOLOGICAL CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE-INDUCED EXCITATION OF AFFERENT CERVICAL VAGUS NERVE IN ANESTHETIZED RATS

被引:35
作者
YOSHIOKA, M [1 ]
IKEDA, T [1 ]
ABE, M [1 ]
TOGASHI, H [1 ]
MINAMI, M [1 ]
SAITO, H [1 ]
机构
[1] HIGASHI NIPPON GAKUEN UNIV,FAC PHARMACEUT SCI,DEPT PHARMACOL,ISHIKARI,HOKKAIDO 06102,JAPAN
关键词
5-HYDROXYTRYPTAMINE; SENSORY NEURON; VAGUS NERVE ACTIVITY; 5-HT RECEPTORS;
D O I
10.1111/j.1476-5381.1992.tb14372.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 An excitatory response to 5-hydroxytryptamine (5-HT) was measured from the afferent vagus nerve of anaesthetized rats. Measurements were determined by an extracellular recording from the whole nerve. 2 Intravenous bolus injection of 5-HT (1.56-100-mu-g kg-1) evoked a dose-dependent excitation of afferent vagus nerve activity. This response was blocked not only by a selective 5-HT3 receptor antagonist, GR38032F (10 and 100-mu-g kg-1), but also by a 5-HT2 receptor antagonist, ketanserin (10 and 100-mu-g kg-1). 3 Both a 5-HT3 receptor agonist, 2-methyl-5-HT (3.12-100-mu-g kg-1), and a 5-HT2 receptor agonist, alpha-methyl-5-HT (3.12-50-mu-g kg-1), produced a dose-dependent excitation of afferent vagus nerve activity. These excitatory effects were antagonized by GR38032F (10-mu-g kg-1) and ketanserin (10-mu-g kg-1), respectively. 4 A 5-HT1 like receptor agonist, 5-carboxamidotryptamine (50-mu-g kg-1), and a putative 5-HT4 receptor agonist, 5-methoxytryptamine (100 Ag kg-1), failed to produce excitatory effects on the afferent vagus nerve. 5 These results suggest that the 5-HT-induced excitatory response of the afferent vagus nerve might be mediated not only via 5-HT3 receptors but also via 5-HT2 receptors in anaesthetized rats. It is unlikely, however, that either 5-HT1-like or putative 5-HT4 receptors are involved in the excitatory response of the afferent vagus nerve to 5-HT.
引用
收藏
页码:544 / 549
页数:6
相关论文
共 22 条
[1]   PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE [J].
BRADLEY, PB ;
ENGEL, G ;
FENIUK, W ;
FOZARD, JR ;
HUMPHREY, PPA ;
MIDDLEMISS, DN ;
MYLECHARANE, EJ ;
RICHARDSON, BP ;
SAXENA, PR .
NEUROPHARMACOLOGY, 1986, 25 (06) :563-576
[2]   PHARMACOLOGICAL PROPERTIES OF GR38032F, A NOVEL ANTAGONIST AT 5-HT3 RECEPTORS [J].
BUTLER, A ;
HILL, JM ;
IRELAND, SJ ;
JORDAN, CC ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (02) :397-412
[3]  
COHEN ML, 1985, J PHARMACOL EXP THER, V232, P770
[4]   NEURONAL 5-HT RECEPTORS IN THE PERIPHERY [J].
FOZARD, JR .
NEUROPHARMACOLOGY, 1984, 23 :1473-1486
[5]   MECHANISM OF THE HYPOTENSIVE EFFECT OF KETANSERIN [J].
FOZARD, JR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (05) :829-838
[6]   THE ACTION OF 5-HYDROXYTRYPTAMINE AND TRYPTAMINE ON AORTIC AND CAROTID SINUS RECEPTORS IN THE CAT [J].
GINZEL, KH ;
KOTTEGODA, SR .
JOURNAL OF PHYSIOLOGY-LONDON, 1954, 123 (02) :277-288
[7]  
HEBEL R, 1986, ANATOMY EMBRYOLOGY L, P188
[8]   5-HYDROXYTRYPTAMINE RECEPTORS OF VISCERAL PRIMARY AFFERENT NEURONS ON RABBIT NODOSE GANGLIA [J].
HIGASHI, H ;
NISHI, S .
JOURNAL OF PHYSIOLOGY-LONDON, 1982, 323 (FEB) :543-567
[9]  
HOYER D, 1988, MOL PHARMACOL, V33, P303
[10]   [H-3]ICS 205-930 LABELS 5-HT3 RECOGNITION SITES IN MEMBRANES OF CAT AND RABBIT VAGUS NERVE AND SUPERIOR CERVICAL-GANGLION [J].
HOYER, D ;
WAEBER, C ;
KARPF, A ;
NEIJT, H ;
PALACIOS, JM .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1989, 340 (04) :396-402